Gan & Lee Pharmaceuticals. (SHA:603087)
China · Delayed Price · Currency is CNY 71.47
+2.64 (3.84%)
Oct 27, 2025, 11:29 AM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 40.97 billion as of October 24, 2025. Its market cap has increased by 80.89% in one year.
Market Cap
40.97B
Enterprise Value
38.73B
Revenue
3.80B
Ranking
n/a
PE Ratio
44.46
Stock Price
71.47
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 40.97B, an increase of 12.02%. That is a compound annual growth rate of 2.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 40.97B | 55.58% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | 74.25B | 103.01% |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 435.31B |
| WuXi AppTec | 306.38B |
| Shenzhen Mindray Bio-Medical Electronics | 267.94B |
| Sichuan Biokin Pharmaceutical | 145.45B |
| Shanghai United Imaging Healthcare | 116.57B |
| Aier Eye Hospital Group | 113.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.03B |
| Yunnan Baiyao Group Co.,Ltd | 100.56B |